Shahar Yoav

Shahar Yoav has 18 years of experience in recombinant proteins and synthetic biology, specializing in fermentation, protein purification, and process optimization. He currently serves as Principal Scientist and Head of Technology at YDLabs, a fermentation pilot facility in Israel focused on the Food-tech and Agri-tech sectors. In this role, Shahar leads tech transfer, fermentation optimization, and scale-up processes to produce recombinant proteins in a cost-effective manner. Before joining YDLabs, Shahar was a senior scientist in the diagnostics industry, where he led R&D and scale-up processes for novel recombinant proteins and enzymes used in diagnostic assays. He has also worked as a project manager in the cleantech industry, designing up-stream and downstream processes for cost-effective enzyme production. Shahar holds a Ph.D. in Biochemistry and Microbiology

Tuesday
May 06
Meet the Next-Gen of Revolutionary Fermentation and Large-Scale Biomanufacturing
12:15 PM

-

1:00 PM

Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of fermentation. Rather than waste money building fermentation capacity from scratch, companies can transform their biomanufacturing processes with external experts. By leveraging their collective experience and economies of scale, CDMOs can harness the power of engineered organisms to drive innovation and efficiency across diverse industries. By seamlessly integrating fermentation with cutting-edge synthetic biology techniques, these global facilities not only boost productivity but also promote environmental sustainability. Through decades of in-house knowledge, strategic industry collaborations, and an unwavering commitment to shaping the future of biotechnology, our leading team isn’t merely anticipating trends; we are actively creating them.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025